Skip to main content

Table 2 Magnesium intake and serum magnesium by dietary intake, physical activity level, depression, metabolic parameter, body fat percentage, body mass index, hsCRP and estimated GFR status

From: Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study

Variables

n

Mg intake (mg/kg)

P

Serum Mg (mmol/L)

P

Dietary intake

     

Energy intake (kcal/kg)

  

0.000

 

0.636

< 25

109

2.8 ± 1.3 ab

 

0.77 ± 0.10

 

25 to 30

47

4.0 ± 1.2 a

 

0.79 ± 0.10

 

>30

54

4.6 ± 2.0 b

 

0.79 ± 0.08

 

Protein intake (g/kg)

  

0.000

 

0.172

< 0.8

115

2.9 ± 1.3 ab

 

0.77 ± 0.10

 

0.8 to 1.0

48

3.7 ± 1.2 ac

 

0.80 ± 0.09

 

>1.0

47

5.0 ± 2.0 bc

 

0.79 ± 0.08

 

Physical activity level

  

0.002

 

0.024

Low

48

2.8 ± 1.4 a b

 

0.79 ± 0.11

 

Moderate

83

3.8 ± 1.7 a

 

0.80 ± 0.09 c

 

High

79

3.8 ± 1.7 b

 

0.76 ± 0.08 c

 

Depression (DSM-IV)

  

0.001

 

0.554

< 5 symptoms

147

3.8 ± 1.7

 

0.78 ± 0.10

 

≧ 5 symptoms

63

3.0 ± 1.4

 

0.78 ± 0.09

 

Metabolic parameters

     

HbA1c (%)

  

0.709

 

0.558

< 7.0

103

3.6 ± 1.6

 

0.79 ± 0.08

 

≧ 7.0

107

3.5 ± 1.7

 

0.78 ± 0.11

 

HDL-cholesterol (mg/dL)

  

0.051

 

0.659

≧ 40 for men or ≧ 50 for women

114

3.8 ± 1.8

 

0.78 ± 0.09

 

< 40 for men or < 50 for women

96

3.3 ± 1.5

 

0.78 ± 0.10

 

Triglycerides (mg/dL)

  

0.452

 

0.456

< 150

172

3.6 ± 1.7

 

0.78 ± 0.10

 

≧ 150

38

3.4 ± 1.4

 

0.79 ± 0.08

 

Blood pressure (mmHg)

  

0.344

 

0.669

Systolic BP < 130 / Diastolic BP < 80

64

3.7 ± 2.0

 

0.79 ± 0.09

 

Systolic BP ≧ 130 / Diastolic BP ≧ 80

146

3.5 ± 1.5

 

0.78 ± 0.10

 

Waist circumference (cm)

  

0.000

 

0.687

< 80 for men or < 90 for women

44

4.6 ± 2.2

 

0.78 ± 0.10

 

≧ 80 for men or ≧ 90 for women

166

3.3 ± 1.4

 

0.78 ± 0.09

 

Metabolic syndrome

  

0.013

 

0.234

< 3 components

54

4.2 ± 2.3

 

0.80 ± 0.10

 

≧ 3 components

156

3.3 ± 1.4

 

0.78 ± 0.09

 

Body Fat percentage (%)

  

0.000

 

0.873

< 25 for men or < 30 for women

101

4.0 ± 1.9

 

0.78 ± 0.09

 

≧ 25 for men or ≧ 30 for women (obese)

109

3.1 ± 1.4

 

0.78 ± 0.10

 

Body mass index (kg/m2)

  

0.000

 

0.803

< 27

151

3.9 ± 1.7

 

0.78 ± 0.10

 

≧ 27 (obese)

59

2.8 ± 1.3

 

0.78 ± 0.09

 

High-sensitivity CRP (mg/L)

  

0.246

 

0.186

< 1 Low risk

57

3.9 ± 1.9

 

0.76 ± 0.10

 

1 to 3 Moderate risk

105

3.5 ± 1.6

 

0.79 ± 0.10

 

> 3 High risk

35

3.3 ± 1.5

 

0.80 ± 0.08

 

Estimated GFR(ml/min)

  

0.067

 

0.363

≧ 90 CKD stage 1

30

4.0 ± 1.7

 

0.76 ± 0.10

 

60 - 89 CKD stage 2

121

3.6 ± 1.8

 

0.79 ± 0.09

 

30 - 59 CKD stage 3

59

3.1 ± 1.4

 

0.78 ± 0.11

 
  1. 1. Abbreviations: HbA1C, glycated hemoglobin; HDL, high-density lipoprotein; BP, blood pressure; CRP, C-reactive protein; GFR, glomerular filtration rate; CKD, chronic kidney disease.
  2. 2. The t test was used for the difference in the means of two groups. The means of more than two groups were compared using one-way ANOVA followed by Scheffe’s multiple comparisons test. a-a, b-b, c-c indicates significant difference between two groups. Data are means ± SD. Significant difference (p < 0.05).